Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Lifecore Biomedical Inc.
LFCRCurrent price
6.68 USD
-0.43 USD (-6.05%)
Last closed
7.09 USD
Company
www.lifecore.com
ISIN
unknown
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Capitalization
248 213 968 USD
Yield for 12 month
-13.25 %
1Y
3Y
5Y
10Y
15Y
LFCR
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota. Address: 3515 Lyman Boulevard, Chaska, MN, United States, 55318
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7 USDP/E ratio
51.8462Dividend Yield
–Current Year
+128 261 000 USD
Last Year
+185 786 000 USD
Current Quarter
+24 705 000 USD
Last Quarter
+37 886 000 USD
Current Year
+41 850 000 USD
Last Year
+50 553 000 USD
Current Quarter
+5 387 000 USD
Last Quarter
+17 272 000 USD
Key Figures LFCR
1 year
3 years
5 years
10 years
EBITDA
-674 000 USD
Operating Margin TTM
PE Ratio
51.8462
Return On Assets TTM
-2.25 %
PEG Ratio
3.513
Return On Equity TTM
17.29 %
Wall Street Target Price
7 USD
Revenue TTM
128 444 000 USD
Book Value
-0.13 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
0.7 %
Dividend Yield
–
Gross Profit TTM
27 292 000 USD
Earnings per share
0.13 USD
Diluted Eps TTM
0.13 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
5.09 %
Dividend Analytics LFCR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History LFCR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation LFCR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
51.8462
Forward PE
8.673
Enterprise Value Revenue
2.955
Price Sales TTM
1.9325
Enterprise Value EBITDA
11.1684
Price Book MRQ
15.3467
Financials LFCR
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators LFCR
For 52 weeks
3.68 USD
8.9 USD
50 Day MA
5.14 USD
Shares Short Prior Month
2 788 571
200 Day MA
5.92 USD
Short Ratio
18.72
Shares Short
2 672 743
Short Percent
11.8 %
BeatStart